Organogenesis Holdings Inc.
ORGO
$2.48
$0.104.20%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -58.19% | 77.70% | 30.66% | -22.62% | -21.17% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -57.06% | 78.13% | 30.98% | -22.44% | -21.17% |
| Cost of Revenue | 8.64% | 44.08% | 35.29% | -5.37% | -17.33% |
| Gross Profit | -81.81% | 89.18% | 29.68% | -27.38% | -22.53% |
| SG&A Expenses | -15.42% | 35.63% | 10.35% | -3.57% | 0.26% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.31% | 33.29% | 18.14% | -7.82% | -6.11% |
| Operating Income | -222.28% | 589.01% | 255.09% | -221.56% | -423.86% |
| Income Before Tax | -165.57% | 518.62% | 263.39% | 18.61% | -493.67% |
| Income Tax Expenses | -120.71% | 664.61% | 93.75% | -197.56% | -209.41% |
| Earnings from Continuing Operations | -182.10% | 469.53% | 74.90% | 44.89% | -797.29% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -182.10% | 469.53% | 74.90% | 44.89% | -797.29% |
| EBIT | -222.28% | 589.01% | 255.09% | -221.56% | -423.86% |
| EBITDA | -247.01% | 413.19% | 153.95% | -147.72% | -13,234.71% |
| EPS Basic | -156.96% | 510.82% | 23.12% | 50.78% | -975.47% |
| Normalized Basic EPS | -232.28% | 603.24% | 304.73% | -227.76% | -361.65% |
| EPS Diluted | -156.96% | 555.36% | 22.22% | 50.23% | -755.00% |
| Normalized Diluted EPS | -232.28% | 587.63% | 296.69% | -227.76% | -361.65% |
| Average Basic Shares Outstanding | 1.19% | -2.13% | -4.29% | -4.31% | -4.22% |
| Average Diluted Shares Outstanding | 1.19% | 0.03% | -2.30% | -4.31% | -4.22% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |